Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > Reason(s) For Clinical Trials
View:
Post by Smokey1958 on Jan 12, 2022 11:50am

Reason(s) For Clinical Trials

Throughout the pandemic companies that have produced a rapid antigen test and applied for an EUA had at least 2 FDA hurdles. The first was to supply test data to demonstrate the device worked (which included no cross reactivity issues) and could be used in a clinical setting and/or by health care professionals in a public setting. That would represent their first submission for approval. Months later (over the last year anyway) was a second submission for application for at home use.

While purely speculation on my part it appears THRM either through its summary of invitro tests and/or its trials in Brazil  paased the first test ...with the exception of the cross reactivity tests which would have been carried out sometime after Rob's second last interview. This is when he mentioned this. It also seems that because of timing, the FDA "packaged" the application process into one ...to include the at home clinical trials as part of one whole submission. This is the critical piece for me in believing that unless something went horribly wrong with individuals being able to take their own saliva samples that an FDA EUA has never been a matter of if but instead of when it would be provided.

It makes no sense to have otherwise carried this on for months!!!
Comment by mooseslayer on Jan 12, 2022 11:58am
I agree...I think that the FDA Ask for these latest trials was to allow for Home tests. That is why they also asked for proof manufacturing was in place for a minimum 500K test per week. If they had found something wrong with the device or the data they would have already been dismissed.
Comment by nrv090909 on Jan 12, 2022 12:00pm
I agree. FDA would never ask for minimum 500K proof of scaling if they thought Acuvid was garbadge. It will get approved, that is why they asked for minimums. I think once they submit data it is approval. Great time to buy cheapies right now in the 30's. IMO. Good luck to all longs, shorts and shorters and day traders. 
Comment by Commoncents on Jan 12, 2022 12:26pm
It's going to get approval soon imo. Too many things adding up. I added in the 30's today: it was too tempting not to add with FDA coming imo. 
Comment by Trueblood on Jan 12, 2022 2:39pm
It's a production pre requirement for all submissions has nothing to do with Acuvid.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities